Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Chemomab Therapeutics Ltd. buy Global_Player

Chemomab Therapeutics Ltd.
Start price
€1.10
18.06.25 / 50%
Target price
-
18.06.26
Performance (%)
-3.64%
End price
€1.06
21.06.25
Summary
This prediction ended on 21.06.25 with a price of €1.06. With a performance of -3.64%, the BUY prediction for Chemomab Therapeutics Ltd. by Global_Player closed slightly in the red. Global_Player has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
Chemomab Therapeutics Ltd. - -
iShares Core DAX® 0.734% 1.458%
iShares Nasdaq 100 -2.686% -0.146%
iShares Nikkei 225® -2.261% -2.729%
iShares S&P 500 -1.346% 0.467%

According to Global_Player what are the pros and cons of Chemomab Therapeutics Ltd. for the foreseeable future?

Pros
Could be worthwhile Investment >10% per year
Cons

Comments by Global_Player for this prediction

In the thread Chemomab Therapeutics Ltd. diskutieren

Buy Chemomab Therapeutics Ltd.

Global_Player 
0
Report Share
18.06.25 Buy -3.64%
In the thread Trading Chemomab Therapeutics Ltd.
Prediction Buy
Perf. (%) -3.64%
Target price
Change
Ends at 18.06.26

Buy beendet

Global_Player 
0
Report Share
21.06.25

Stopped prediction by Global_Player for Chemomab Therapeutics Ltd.

buy
Chemomab Therapeutics Ltd.

Start price
Target price
Perf. (%)
€1.14
24.03.25
-
24.03.26
-12.72%
29.03.25

Could be worthwhile Investment >10% per year
Global_Player 
24.03.25 50%
buy
Chemomab Therapeutics Ltd.

Start price
Target price
Perf. (%)
€1.23
04.03.25
-
04.03.26
6.50%
15.03.25

Global_Player 
04.03.25 50%
buy
Chemomab Therapeutics Ltd.

Start price
Target price
Perf. (%)
€2.12
19.01.25
-
19.01.26
-6.60%
01.02.25

Global_Player 
19.01.25 50%